Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
T2 Biosystems's operating assets for the quarter that ended in Sep. 2024 was $16.00 Mil. T2 Biosystems's operating liabilities for the quarter that ended in Sep. 2024 was $10.85 Mil. T2 Biosystems's Total Assets for the quarter that ended in Jun. 2024 was $21.72 Mil. Therefore, T2 Biosystems's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.24.
T2 Biosystems Scaled Net Operating Assets Related Terms
T2 Biosystems Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for T2 Biosystems's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TTOO vs IDTA, NSTM, TMO: Scaled Net Operating Assets Comparison
For the Diagnostics & Research subindustry, T2 Biosystems's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T2 Biosystems Scaled Net Operating Assets vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where T2 Biosystems's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.24 mean?
T2 Biosystems (TTOO) has a Scaled Net Operating Assets of 0.24 as of Sep. 2024. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on T2 Biosystems and its competitors.
Is T2 Biosystems' Scaled Net Operating Assets too high?
T2 Biosystems' current Scaled Net Operating Assets is 0.24. Overall, T2 Biosystems has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does T2 Biosystems' Scaled Net Operating Assets compare to IDTA and NSTM?
T2 Biosystems' Scaled Net Operating Assets of 0.24 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Diagnostics & Research company?
A good Scaled Net Operating Assets depends on the Medical Diagnostics & Research industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on T2 Biosystems and its competitors. T2 Biosystems's current Scaled Net Operating Assets is 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T2 Biosystems stock overvalued right now?
T2 Biosystems (TTOO) has a current Scaled Net Operating Assets of 0.24. The current Scaled Net Operating Assets is 0.24. T2 Biosystems' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For T2 Biosystems (TTOO), the current Scaled Net Operating Assets is 0.24 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
12GF Score
Get the complete analysis for TTOO
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TTOO has been successfully added to your 
